Stockreport

Impetigo Drugs Global Strategic Business Report 2024 - Fusidane Drug Segment is Expected to Reach US$883.5 Million by 2030, with a CAGR of a 5.1% [Yahoo! Finance]

NovaBay Pharmaceuticals, Inc.  (NBY) 
NASDAQ:AMEX Investor Relations: novabay.com/investors
PDF The global market for Impetigo Drugs was estimated at US$1.5 Billion in 2023, and is projected to reach US$2.1 Billion by 2030, growing at a CAGR of 4.5% from 2023 to 2 [Read more]